✦ LIBER ✦

Effects of dopaminergic treatment on bladder function in Parkinson's disease

✍ Scribed by Kristian Winge; Lene M. Werdelin; Kurt K. Nielsen; Hans Stimpel

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 155 KB
Volume: 23
Category: Article
ISSN: 0733-2467
DOI: 10.1002/nau.20054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparing bromocriptine effects with lev

Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease

✍ Tomoyuki Uchiyama; Ryuji Sakakibara; Tatsuya Yamamoto; Takashi Ito; M Chiharu Ya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract To evaluate the effects of bromocriptine on bladder function in Parkinson's disease (PD) patients and compare these effects with those of (L‐dopa). We recruited 8 patients with PD. Urodynamic study (UDS) was performed before and 1 hour after administering 100 mg L‐dopa/decarboxylase inh

Dopaminergic modulation of cortical func

Dopaminergic modulation of cortical function in patients with Parkinson's disease

✍ Venkata S. Mattay; Alessandro Tessitore; Joseph H. Callicott; Alessandro Bertoli 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 2 views

## Abstract Patients with idiopathic Parkinson's disease suffer not only from classic motor symptoms, but from deficits in cognitive function, primarily those subserved by the prefrontal cortex as well. The aim of the current study was to investigate the modulatory effects of dopaminergic therapy o

Brain dopaminergic modulation associated

Brain dopaminergic modulation associated with executive function in Parkinson's disease

✍ Karim Farid; Igor Sibon; Dominique Guehl; Emmanuel Cuny; Pierre Burbaud; Michèle 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

## Abstract The progressive development of deficits in executive functions, including action planning, is a well‐known complication of Parkinson's disease. A dysfunction of the prefrontal lobe, which is known to be involved in the control of inhibitory processes, could explain the difficulties in i

Quetiapine as treatment for dopaminergic

Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease

✍ Mark S. Baron; W. Brian Dalton 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

Effects of central dopaminergic stimulat

Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease

✍ Dr. F. Tison; L. Wiart; M. Guatterie; N. Fouillet; V. Lozano; P. Henry; M. Barat 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB

## Abstract Swallowing disorders are common in Parkinson's disease but are of obscure and complex nature and pathophysiology. The effect of central dopaminergic stimulation on disordered swallowing is not well known. We studied the effects of apomorphine (in combination with domperidone) on buccoli

Dopaminergic influence on disturbed spat

Dopaminergic influence on disturbed spatial discrimination in Parkinson's disease

✍ Hae-Won Shin; Suk Y. Kang; Young H. Sohn 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Abstract Various sensory symptoms and disturbed sensory perception are often observed in patients with idiopathic Parkinson's disease (PD). The basis of sensory disturbance in PD is unknown but possibly reflects a role for the basal ganglia in sensory processing. To investigate the relationship